Contact this trialFirst, we need to learn more about you.
Sodium Glucose Transporter Inhibitor
Empagliflozin for Congenital Heart Disease
Recruiting2 awardsPhase 4
Pittsburgh, Pennsylvania
"This trial aims to see if a new drug called Empagliflozin (Jardiance) can help adult patients with congenital heart disease. The goal is to determine if this drug is
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.